SCHEMBL13900720

SCHEMBL13900720

CCCN(CC(C)(C)C)C(=O)Nc1ccc(OC)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
ALDH1A1 P00352 2/20 0.45
PDK1 Q15118 1/20 0.45
PDK2 Q15119 1/20 0.45
PDK3 Q15120 1/20 0.45
PDK4 Q16654 1/20 0.45
PKM P14618 1/20 0.45
SAE1 Q9UBE0 1/20 0.44
UBA2 Q9UBT2 1/20 0.44
TP53 P04637 1/20 0.44
ALOX15 P16050 1/20 0.44
MAPT P10636 3/20 0.44
MAPK1 P28482 1/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13900239 0.83 ALDH1A1 (0.51) RAB9ASMN1; SMN2KMT2AMEN1ALDH1A1
SCHEMBL13911251 0.82 ALDH1A1 (0.58) RAB9ASMN1; SMN2KMT2AMEN1L3MBTL1
SCHEMBL13900754 0.81 ALDH1A1 (0.57) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL9435378 0.78 CNR1 (0.56) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL3048258 0.75 KMT2A (0.56) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL13900722 0.75 MEN1 (0.55) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL10891080 0.74 HDAC6 (0.63) RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL20846652 0.74 SMN1; SMN2 (0.53) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL30969214 0.73 NPC1 (0.60) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL19002443 0.72 MEN1 (0.63) NPC1RAB9ASMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504391-B2 Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders SCHERING CORPORATION (US) 2009-03-17 US disclosed